These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 37353937)

  • 1. Caregivers' Attitudes Toward Treatment Length for Persons in Swedish Opioid Agonist Treatment. A Qualitative Interview Study.
    Nehlin C; Brander CW; Öster C
    J Psychoactive Drugs; 2024; 56(3):373-379. PubMed ID: 37353937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Provider and patient perspectives on barriers to buprenorphine adherence and the acceptability of video directly observed therapy to enhance adherence.
    Godersky ME; Saxon AJ; Merrill JO; Samet JH; Simoni JM; Tsui JI
    Addict Sci Clin Pract; 2019 Mar; 14(1):11. PubMed ID: 30867068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Care Integration for Hepatitis C Virus Treatment Through Facilitated Telemedicine Within Opioid Treatment Programs: Qualitative Study.
    Dickerson SS; George SJ; Ventuneac A; Dharia A; Talal AH
    J Med Internet Res; 2024 Jun; 26():e53049. PubMed ID: 38865703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Future of Opioid Agonist Therapies in Ukraine: A Qualitative Assessment of Multilevel Barriers and Ways Forward to Promote Retention in Treatment.
    Bojko MJ; Mazhnaya A; Marcus R; Makarenko I; Islam Z; Filippovych S; Dvoriak S; Altice FL
    J Subst Abuse Treat; 2016 Jul; 66():37-47. PubMed ID: 27211995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Opioid Use Disorder in Canadian Psychosocial Addiction Programs: A National Survey of Policy, Attitudes, and Practice.
    Hodgins DC; Budd M; Czukar G; Dubreucq S; Jackson LA; Rush B; Quilty LC; Adams D; Cameron Wild T
    Can J Psychiatry; 2022 Aug; 67(8):638-647. PubMed ID: 35257596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practitioner perspectives on working with older patients in opioid agonist treatment (OAT) in Norway: opportunities and challenges.
    Todd-Kvam J; Clausen T
    Addict Sci Clin Pract; 2024 May; 19(1):44. PubMed ID: 38783382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients' Perspectives on Coming Off Opioid Agonist Treatment: A Qualitative Study.
    Nehlin C; Bäckström J; Brander CW; Öster C
    Subst Abuse; 2022; 16():11782218221107021. PubMed ID: 35754979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Becoming our young people's case managers: caregivers' experiences, needs, and ideas for improving opioid use treatments for young people using opioids.
    Marchand K; Turuba R; Katan C; Brasset C; Fogarty O; Tallon C; Fairbank J; Mathias S; Barbic S
    Subst Abuse Treat Prev Policy; 2022 May; 17(1):34. PubMed ID: 35525987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
    Velasquez M; Flannery M; Badolato R; Vittitow A; McDonald RD; Tofighi B; Garment AR; Giftos J; Lee JD
    Addict Sci Clin Pract; 2019 Oct; 14(1):37. PubMed ID: 31570100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis.
    Yarborough BJ; Stumbo SP; McCarty D; Mertens J; Weisner C; Green CA
    Drug Alcohol Depend; 2016 Mar; 160():112-8. PubMed ID: 26796596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tapering opioids: a comprehensive qualitative review.
    Davis MP; Digwood G; Mehta Z; McPherson ML
    Ann Palliat Med; 2020 Mar; 9(2):586-610. PubMed ID: 32008341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the ideal time to begin tapering opioid agonist treatment? A protocol for a retrospective population-based comparative effectiveness study in British Columbia, Canada.
    Yan R; Kurz M; Guerra-Alejos BC; Min JE; Bach P; Greenland S; Gustafson P; Karim E; Korthuis PT; Loughin T; McCandless L; Platt RW; Schnepel K; Seaman S; Socías ME; Wood E; Xie H; Nosyk B
    BMJ Open; 2024 Apr; 14(4):e083453. PubMed ID: 38684262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid agonist treatment (OAT) experiences and release plans among federally incarcerated individuals with opioid use disorder (OUD) in Ontario, Canada: a mixed-methods study.
    Russell C; Nafeh F; Pang M; MacDonald SF; Derkzen D; Rehm J; Fischer B
    BMC Public Health; 2022 Mar; 22(1):436. PubMed ID: 35246083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceived healthcare stigma among patients in opioid substitution treatment: a qualitative study.
    Garpenhag L; Dahlman D
    Subst Abuse Treat Prev Policy; 2021 Oct; 16(1):81. PubMed ID: 34702338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitudes and beliefs among Georgia addiction treatment staff about medication for opioid use disorder in adolescents, young adults, and adults: a multi-mixed methods study.
    Welsh JW; Mataczynski MJ; Passetti LL; Hunter BD; Godley MD
    Am J Drug Alcohol Abuse; 2022 May; 48(3):347-355. PubMed ID: 35416739
    [No Abstract]   [Full Text] [Related]  

  • 16. A qualitative analysis of barriers to opioid agonist treatment for racial/ethnic minoritized populations.
    Husain JM; Cromartie D; Fitzelle-Jones E; Brochier A; Borba CPC; Montalvo C
    J Subst Abuse Treat; 2023 Jan; 144():108918. PubMed ID: 36403456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged-release opioid agonist therapy: qualitative study exploring patients' views of 1-week, 1-month, and 6-month buprenorphine formulations.
    Neale J; Tompkins CNE; Strang J
    Harm Reduct J; 2019 Apr; 16(1):25. PubMed ID: 30943990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare staff's perspectives on long-acting injectable buprenorphine treatment: a qualitative interview study.
    Nordgren J; Monwell B; Johnson B; Gunnarsson NV; Capusan AJ
    Addict Sci Clin Pract; 2024 Apr; 19(1):25. PubMed ID: 38581022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients' Experience With Opioid Tapering: A Conceptual Model With Recommendations for Clinicians.
    Henry SG; Paterniti DA; Feng B; Iosif AM; Kravitz RL; Weinberg G; Cowan P; Verba S
    J Pain; 2019 Feb; 20(2):181-191. PubMed ID: 30243859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Associated With Primary Family Caregivers' Perceptions on Quality of Family-Centered Care in Mental Health Practice.
    Hsiao CY; Lu HL; Tsai YF
    J Nurs Scholarsh; 2019 Nov; 51(6):680-688. PubMed ID: 31697045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.